However, ultimately, new targets or new small-molecule compounds are to be discovered, with the intent of being applied in the clinic to treat patients afflicted by cancers, while the humanin vivo environment is complex, and it is not the end point to find a small molecule compound that regulates PD-L1. Here, CD274 is linked to cancer.